These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 29226727)

  • 1. High expression of interleukine-1 receptor antagonist in rheumatoid arthritis: Association with IL1RN*2/2 genotype.
    Ramírez-Pérez S; De la Cruz-Mosso U; Hernández-Bello J; Martínez-Bonilla GE; Ramírez-Dueñas MG; Pereira-Suárez AL; Parra Rojas I; Martínez-López E; Macías-Barragán J; Muñoz-Valle JF
    Autoimmunity; 2017 Dec; 50(8):468-475. PubMed ID: 29226727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-1B and IL-1RN gene polymorphisms in rheumatoid arthritis: relationship with protein plasma levels and response to therapy.
    Tolusso B; Pietrapertosa D; Morelli A; De Santis M; Gremese E; Farina G; Carniello SG; Del Frate M; Ferraccioli G
    Pharmacogenomics; 2006 Jul; 7(5):683-95. PubMed ID: 16886894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of 86 bp variable number of tandem repeat (VNTR) polymorphism of interleukin-1 receptor antagonist (IL1RN) with susceptibility and clinical activity in rheumatoid arthritis.
    Ramírez-Pérez S; Salazar-Páramo M; Pineda-Monjarás S; De la Cruz-Mosso U; Hernández-Bello J; Martínez-Bonilla GE; Pereira-Suárez AL; Muñoz-Valle JF
    Clin Rheumatol; 2017 Jun; 36(6):1247-1252. PubMed ID: 28342152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No association of interleukin-1 receptor antagonist VNTR polymorphism and rheumatoid arthritis susceptibility: a meta analysis.
    Xue J; Mou L; Lu X; Wu H
    Clin Exp Rheumatol; 2010; 28(5):654-60. PubMed ID: 20863445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-1β, Interleukin1-Ra, Interleukin-10, and tumor necrosis factor-α polymorphisms in Tunisian patients with rheumatoid arthritis.
    Lagha A; Zidi S; Stayoussef M; Gazouani E; Kochkar R; Kochbati S; Almawi WY; Yacoubi-Loueslati B
    Pathol Biol (Paris); 2015 Sep; 63(4-5):179-84. PubMed ID: 26003199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of interleukin-1 receptor antagonist (IL-1Ra) gene 86 bp VNTR polymorphism on recurrent pregnancy loss: a case-control study.
    Hajizadeh YS; Emami E; Nottagh M; Amini Z; Maroufi NF; Azimian SH; Isazadeh A
    Horm Mol Biol Clin Investig; 2017 May; 30(3):. PubMed ID: 28593919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism of the interleukin-1 receptor antagonist gene: a factor in susceptibility to rheumatoid arthritis in a Spanish population.
    Carreira PE; Gonzalez-Crespo MR; Ciruelo E; Pablos JL; Santiago B; Gomez-Camara A; Gomez-Reino JJ
    Arthritis Rheum; 2005 Oct; 52(10):3015-9. PubMed ID: 16200608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 1 receptor antagonist (
    Attur M; Zhou H; Samuels J; Krasnokutsky S; Yau M; Scher JU; Doherty M; Wilson AG; Bencardino J; Hochberg M; Jordan JM; Mitchell B; Kraus VB; Abramson SB
    Ann Rheum Dis; 2020 Mar; 79(3):400-407. PubMed ID: 31852669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of IL-1RN intron 2 variable number of tandem repeats (VNTR) polymorphism on bipolar disorder.
    Rafiei A; Hosseini SH; Taheri M; Hosseni-khah Z; Hajilooi M; Mazaheri Z
    Neuropsychobiology; 2013; 67(2):116-21. PubMed ID: 23406623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haplotypes of the interleukin-1 receptor antagonist gene, interleukin-1 receptor antagonist mRNA levels and the risk of myocardial infarction.
    van Minkelen R; Wettinger SB; de Visser MC; Vos HL; Reitsma PH; Rosendaal FR; Bertina RM; Doggen CJ
    Atherosclerosis; 2009 Mar; 203(1):201-5. PubMed ID: 18703194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interleukin-1 and the interleukin-1 receptor antagonist gene polymorphisms study in patients with rheumatoid arthritis].
    Allam I; Djidjik R; Ouikhlef N; Louahchi S; Raaf N; Behaz N; Abdessemed A; Khaldoun N; Tahiat A; Bayou M; Ladjouze-Rezig A; Ghaffor M
    Pathol Biol (Paris); 2013 Dec; 61(6):264-8. PubMed ID: 23849770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The existence of gender difference in IL-1Ra gene polymorphism.
    Bessler H; Osovsky M; Beilin B; Alcalay Y; Sirota L
    J Interferon Cytokine Res; 2007 Nov; 27(11):931-5. PubMed ID: 18052726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL1RN genetic variations and risk of IPF: a meta-analysis and mRNA expression study.
    Korthagen NM; van Moorsel CH; Kazemier KM; Ruven HJ; Grutters JC
    Immunogenetics; 2012 May; 64(5):371-7. PubMed ID: 22322675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphism in intron 2 of the fetal interleukin-1 receptor antagonist genotype influences midtrimester amniotic fluid concentrations of interleukin-1beta and interleukin-1 receptor antagonist and pregnancy outcome.
    Witkin SS; Vardhana S; Yih M; Doh K; Bongiovanni AM; Gerber S
    Am J Obstet Gynecol; 2003 Nov; 189(5):1413-7. PubMed ID: 14634579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1 receptor antagonist gene polymorphism in patients with rheumatoid arthritis in India.
    Grover S; Tandon S; Misra R; Aggarwal A
    Indian J Med Res; 2006 Jun; 123(6):815-20. PubMed ID: 16885604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRL -1149T allele (rs1341239) is associated with decreased risk of rheumatoid arthritis in population from southern Mexico: analysis of mRNA expression and PRL serum levels.
    Navarro-Zarza JE; Muñoz-Valle JF; Baños-Hernández CJ; Parra-Rojas I; Reyes-Castillo Z; Rangel-Villalobos H; Hernández-Bello J
    Clin Rheumatol; 2019 Aug; 38(8):2089-2097. PubMed ID: 30911943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 1 receptor antagonist mediates the beneficial effects of systemic interferon beta in mice: implications for rheumatoid arthritis.
    Corr M; Boyle DL; Ronacher LM; Lew BR; van Baarsen LG; Tak PP; Firestein GS
    Ann Rheum Dis; 2011 May; 70(5):858-63. PubMed ID: 21216819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1 receptor antagonist gene polymorphism and rheumatoid arthritis.
    Lee YH; Kim HJ; Rho YH; Choi SJ; Ji JD; Song GG
    Rheumatol Int; 2004 May; 24(3):133-6. PubMed ID: 14872281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility for and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of the TNF-alpha, IL-1beta, and IL-1Ra genes.
    Cvetkovic JT; Wallberg-Jonsson S; Stegmayr B; Rantapaa-Dahlqvist S; Lefvert AK
    J Rheumatol; 2002 Feb; 29(2):212-9. PubMed ID: 11838837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Clinical Significance of Interleukin-1 Receptor Antagonist +2018 Polymorphism in Rheumatoid Arthritis.
    Ismail E; Nofal OK; Sakthiswary R; Shaharir SS; Sridharan R
    PLoS One; 2016; 11(4):e0153752. PubMed ID: 27105431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.